Tempest Therapeutics (TPST)
(Delayed Data from NSDQ)
$1.30 USD
+0.02 (1.56%)
Updated Sep 26, 2024 03:59 PM ET
After-Market: $1.30 0.00 (0.00%) 5:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (89 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.58 | 9.99 |
Current Quarter Estimate | -0.37 | -1.06 | 61.00 |
Year Ago Quarter Estimate | -0.48 | -0.06 | 54.84 |
Next Quarter Estimate | -0.38 | -1.85 | 63.00 |
Next Year Estimate | -1.36 | 12.67 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 25.13 | 20.80 | 15.67 |
Next Year | 4.90 | 16.30 | 11.34 |
Last 5 Years | NA | 7.80 | 8.10 |
Next 5 Years | NA | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -1.82 |
Price/Book (MRQ) | 1.58 | 1.65 |
Price/Cash Flow (MRFY) | NA | 8.75 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -58.89% |
Return on Equity (TTM) | -201.10% | -58.88% |
Debt to Equity (MRQ) | 0.12 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.